January 2026 Jubilant Ingrevia commissioned its new food-grade and pharmaceutical-grade niacinamide (vitamin B3) manufacturing facility in Gujarat, India, expanding production capacity for vitamin B3 derivatives, including nicotinic acid.
October 2025 Lonza expanded its Capsugel® dosage solutions by introducing new formulations incorporating vitamin B3 ingredients, including nicotinic acid and niacinamide, for nutraceutical applications.
May 2025 Jubilant Ingrevia launched a new portfolio of pharmaceutical-grade vitamin B3 ingredients, strengthening its offerings of nicotinic acid and niacinamide for pharmaceutical and nutrition markets.